iRadimed Corp (IRMD)
49.90
+0.71
(+1.44%)
USD |
NASDAQ |
Nov 05, 09:32
iRadimed Price to Book Value: 7.580 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 7.472 |
| November 01, 2024 | 7.337 |
| October 31, 2024 | 7.484 |
| October 30, 2024 | 8.039 |
| October 29, 2024 | 7.980 |
| October 28, 2024 | 7.901 |
| October 25, 2024 | 7.652 |
| October 24, 2024 | 7.670 |
| October 23, 2024 | 7.667 |
| October 22, 2024 | 7.737 |
| October 21, 2024 | 7.778 |
| October 18, 2024 | 7.868 |
| October 17, 2024 | 7.827 |
| October 16, 2024 | 7.828 |
| October 15, 2024 | 7.646 |
| October 14, 2024 | 7.649 |
| October 11, 2024 | 7.655 |
| October 10, 2024 | 7.455 |
| October 09, 2024 | 7.500 |
| October 08, 2024 | 7.487 |
| October 07, 2024 | 7.414 |
| October 04, 2024 | 7.566 |
| October 03, 2024 | 7.467 |
| October 02, 2024 | 7.528 |
| October 01, 2024 | 7.523 |
| Date | Value |
|---|---|
| September 30, 2024 | 7.637 |
| September 27, 2024 | 7.818 |
| September 26, 2024 | 7.869 |
| September 25, 2024 | 7.853 |
| September 24, 2024 | 7.738 |
| September 23, 2024 | 7.805 |
| September 20, 2024 | 7.63 |
| September 19, 2024 | 7.829 |
| September 18, 2024 | 7.705 |
| September 17, 2024 | 7.733 |
| September 16, 2024 | 7.802 |
| September 13, 2024 | 7.708 |
| September 12, 2024 | 7.614 |
| September 11, 2024 | 7.433 |
| September 10, 2024 | 7.450 |
| September 09, 2024 | 7.156 |
| September 06, 2024 | 7.139 |
| September 05, 2024 | 7.318 |
| September 04, 2024 | 7.400 |
| September 03, 2024 | 7.286 |
| August 30, 2024 | 7.468 |
| August 29, 2024 | 7.474 |
| August 28, 2024 | 7.594 |
| August 27, 2024 | 7.380 |
| August 26, 2024 | 7.462 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.452
Minimum
Mar 20 2020
9.907
Maximum
Jun 16 2023
6.444
Average
6.533
Median
Oct 13 2021
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.666 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.345 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.082 |
Price to Book Value Related Metrics
| PE Ratio | 34.18 |
| PS Ratio | 8.927 |
| PEG Ratio | 2.594 |
| Price to Free Cash Flow | 37.10 |
| Price | 49.90 |
| Earnings Yield | 2.93% |
| Market Cap | 632.40M |
| PEGY Ratio | 2.268 |
| Operating PE Ratio | 29.85 |
| Normalized PE Ratio | 34.18 |